{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:17:26Z","timestamp":1790183846305,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005014","name":"Avicenna Research Institute","doi-asserted-by":"crossref","award":["88-49"],"award-info":[{"award-number":["88-49"]}],"id":[{"id":"10.13039\/501100005014","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tehran University of Medical Sciences","award":["8723"],"award-info":[{"award-number":["8723"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.vaccine.2014.09.013","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T13:46:46Z","timestamp":1411134406000},"page":"6659-6666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection"],"prefix":"10.1016","volume":"32","author":[{"given":"Amir","family":"Ghasemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood","family":"Jeddi-Tehrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Salari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir-Hassan","family":"Zarnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.09.013_bib0005","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.micinf.2013.10.008","article-title":"The Brucella pathogens are polarized bacteria","volume":"15","author":"Van der Henst","year":"2013","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0010","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1056\/NEJMra050570","volume":"352","author":"Pappas","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.20506\/rst.32.1.2201","article-title":"Recent developments in livestock and wildlife brucellosis vaccination","volume":"32","author":"Olsen","year":"2013","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0020","first-page":"743509","article-title":"A history of the development of Brucella vaccines","volume":"2013","author":"Avila-Calderon","year":"2013","journal-title":"Bio-Med Res Int"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0025","first-page":"255","article-title":"Brucella melitensis infection in sheep: present and future","volume":"29","author":"Garin-Bastuji","year":"1998","journal-title":"Vet Res"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0030","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0378-1135(02)00248-1","article-title":"Incidence and control of brucellosis in the near east region","volume":"90","author":"Refai","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0035","doi-asserted-by":"crossref","first-page":"4017","DOI":"10.1016\/j.vaccine.2012.04.036","article-title":"Invasive Escherichia coli vaccines expressing Brucella melitensis outer membrane proteins 31 or 16 or periplasmic protein BP26 confer protection in mice challenged with B. melitensis","volume":"30","author":"Gupta","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0040","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.molimm.2014.06.017","article-title":"Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice","volume":"62","author":"Ghasemi","year":"2014","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0045","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1016\/j.vaccine.2014.06.012","article-title":"Evaluation of immunogenicity and protective efficacy of a plasmid DNA vaccine encoding ribosomal protein L9 of Brucella abortus in BALB\/c mice","volume":"32","author":"Jain","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0050","doi-asserted-by":"crossref","first-page":"6129","DOI":"10.1016\/j.vaccine.2013.07.041","article-title":"The vaccine candidate BLSOmp31 protects mice against Brucella canis infection","volume":"31","author":"Clausse","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0055","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1016\/j.vaccine.2013.06.013","article-title":"Protective effect of a DNA vaccine containing an open reading frame with homology to an ABC-type transporter present in the genomic island 3 of Brucella abortus in BALB\/c mice","volume":"31","author":"Riquelme-Neira","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0060","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vetmic.2012.07.016","article-title":"Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB\/c mice","volume":"161","author":"Li","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0065","doi-asserted-by":"crossref","first-page":"e29552","DOI":"10.1371\/journal.pone.0029552","article-title":"Immunization of mice with recombinant protein CobB or AsnC confers protection against Brucella abortus infection","volume":"7","author":"Fu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11259-009-9337-x","article-title":"Protection of mice against Brucella abortus 544 challenge by vaccination with recombinant OMP28 adjuvanted with CpG oligonucleotides","volume":"34","author":"Kaushik","year":"2010","journal-title":"Vet Res Commun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.biologicals.2012.01.002","article-title":"Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB\/c mice","volume":"40","author":"Al-Mariri","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/j.1574-695X.2010.00758.x","article-title":"Immunization of mice with recombinant S-adenosyl-l-homocysteine hydrolase protein confers protection against Brucella melitensis infection","volume":"61","author":"Yang","year":"2011","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.molimm.2011.08.009","article-title":"Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine","volume":"49","author":"Yang","year":"2011","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0090","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1128\/IAI.01151-08","article-title":"Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection","volume":"77","author":"Pasquevich","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0095","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12866-014-0223-5","article-title":"Replication of Brucella abortus and Brucella melitensis in fibroblasts does not require Atg5-dependent macroautophagy","volume":"14","author":"Hamer","year":"2014","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0100","first-page":"19","article-title":"Immune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins","volume":"5","author":"Ghasemi","year":"2013","journal-title":"Iran J Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0105","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1073\/pnas.81.3.848","article-title":"Major heat shock gene of Drosophila and the Escherichia coli heat-inducible dnaK gene are homologous","volume":"81","author":"Bardwell","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0110","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1126\/science.272.5268.1606","article-title":"Structural analysis of substrate binding by the molecular chaperone DnaK","volume":"272","author":"Zhu","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0115","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1016\/j.vaccine.2007.07.002","article-title":"Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB\/c mice","volume":"25","author":"Delpino","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2958.1996.tb02510.x","article-title":"Participation of the molecular chaperone DnaK in intracellular growth of Brucella suis within U937-derived phagocytes","volume":"20","author":"Kohler","year":"1996","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1286-4579(02)00075-8","article-title":"The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB\/c mice","volume":"5","author":"Estein","year":"2003","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0130","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/IAI.73.12.8079-8088.2005","article-title":"Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0135","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1128\/IAI.73.11.7297-7303.2005","article-title":"Selection of protective epitopes for Brucella melitensis by DNA vaccination","volume":"73","author":"Yang","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0140","first-page":"192","article-title":"Immunogenicity assessment of Brucella mellitensis HSP and TF proteins by immunized rabbit serum","volume":"12","author":"Ghasemi","year":"2013","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0145","first-page":"172","article-title":"In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate","volume":"17","author":"Ghasemi","year":"2014","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0150","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.vaccine.2006.12.004","article-title":"Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization","volume":"25","author":"Yang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0155","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1128\/IAI.71.9.5238-5244.2003","article-title":"Purification and characterization of an immunogenic aminopeptidase of Brucella melitensis","volume":"71","author":"Contreras-Rodriguez","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0160","doi-asserted-by":"crossref","first-page":"e6875","DOI":"10.5812\/jjm.6875","article-title":"Optimization and efficient purification in production of Brucella melitensis recombinant HSP A and TF proteins with low endotoxin contents","volume":"6","author":"Ghasemi","year":"2013","journal-title":"Jundishapur J Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0165","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0022-1759(90)90029-U","article-title":"Removal of endotoxin from protein solutions by phase separation using Triton X-114","volume":"132","author":"Aida","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/(SICI)1097-0290(19961020)52:2<185::AID-BIT1>3.0.CO;2-M","article-title":"Novel bioseparations using two-phase aqueous micellar systems","volume":"52","author":"Liu","year":"1996","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pep.2005.09.027","article-title":"Single step protocol to purify recombinant proteins with low endotoxin contents","volume":"46","author":"Reichelt","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0180","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0076-6879(90)82008-P","article-title":"Quantitation of protein","volume":"182","author":"Stoscheck","year":"1990","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0185","doi-asserted-by":"crossref","first-page":"e2760","DOI":"10.1371\/journal.pone.0002760","article-title":"Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export","volume":"3","author":"Gonzalez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0190","doi-asserted-by":"crossref","first-page":"4816","DOI":"10.1128\/IAI.69.8.4816-4822.2001","article-title":"Protection of BALB\/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant","volume":"69","author":"Al-Mariri","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0195","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1128\/IAI.73.10.6537-6546.2005","article-title":"A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response","volume":"73","author":"Cassataro","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0200","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1128\/IAI.74.5.2734-2741.2006","article-title":"Protective immunity elicited by a divalent DNA vaccine encoding both the L7\/L12 and Omp16 genes of Brucella abortus in BALB\/c mice","volume":"74","author":"Luo","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0205","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.vaccine.2014.02.058","article-title":"Novel influenza virus vectors expressing Brucella L7\/L12 or Omp16 proteins in cattle induced a strong T-cell immune response, as well as high protectiveness against B. abortus infection","volume":"32","author":"Tabynov","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0210","first-page":"237","article-title":"Pathogenesis and cellular immunity in experimental murine brucellosis","volume":"56","author":"Cheers","year":"1984","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0215","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2567.2001.01258.x","article-title":"Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL\/6 and susceptible BALB\/c mice","volume":"103","author":"Murphy","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0220","doi-asserted-by":"crossref","first-page":"4899","DOI":"10.1128\/IAI.61.11.4899-4901.1993","article-title":"Endogenous gamma interferon mediates resistance to Brucella abortus infection","volume":"61","author":"Zhan","year":"1993","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0225","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0378-1135(02)00222-5","article-title":"Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection","volume":"90","author":"Baldwin","year":"2002","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0230","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cyto.2004.12.009","article-title":"Interferon-gamma associated cytokines and chemokines produced by spleen cells from Brucella-immune mice","volume":"30","author":"Paranavitana","year":"2005","journal-title":"Cytokine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1128\/CMR.16.1.65-78.2003","article-title":"Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans","volume":"16","author":"Ko","year":"2003","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0240","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1023\/A:1015549725819","article-title":"Structure and properties of small heat shock proteins (sHsp) and their interaction with cytoskeleton proteins","volume":"67","author":"Gusev","year":"2002","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0245","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/JB.181.1.83-90.1999","article-title":"Multiple small heat shock proteins in rhizobia","volume":"181","author":"Munchbach","year":"1999","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0250","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/978-3-642-56348-5_3","article-title":"Chaperone function of sHsps","volume":"28","author":"Haslbeck","year":"2002","journal-title":"Prog Mol Subcell Biol"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0255","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.molmed.2007.12.007","article-title":"The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer","volume":"14","author":"Naugler","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0260","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1128\/IAI.63.6.2262-2268.1995","article-title":"Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia","volume":"63","author":"Dalrymple","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0265","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/IAI.05080-11","article-title":"Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses","volume":"79","author":"Clapp","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0270","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.vaccine.2009.12.012","article-title":"Protection of BALB\/c mice against Brucella melitensis 16 M infection induced by vaccination with live Escherchia coli expression Brucella P39 protein","volume":"28","author":"Al-Mariri","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0275","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.vaccine.2006.07.046","article-title":"The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes","volume":"25","author":"Commander","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0280","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/j.vaccine.2007.03.028","article-title":"A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination","volume":"25","author":"Cassataro","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.09.013_bib0285","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/14760584.2.1.129","article-title":"Contemporary approaches to designing and evaluating vaccines against chlamydia","volume":"2","author":"Igietseme","year":"2003","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14012602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T17:49:14Z","timestamp":1598291354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14012602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":57,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0264410X14012602"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}